Resources from the same session
Gene-expression signature for treatment decision-making: Who to test? Which signature?
Presenter: Miguel Martin Jimenez
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Endocrine therapy beyond 5 years: Who to treat and for what duration
Presenter: Lucia Del Mastro
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Optimal management of endocrine therapy toxicity
Presenter: Hope Rugo
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Adjuvant treatment luminal in breast cancer
Resources:
Webcast